Attempts to improve induction treatment in AML patients under 60 years: the impact of mitoxantrone; ARA-C dose and retinoid acid: results of MRC AML 12

AK Burnett; Keith Wheatley; AH Goldstone; A Prentice

Attempts to improve induction treatment in AML patients under 60 years: the impact of mitoxantrone; ARA-C dose and retinoid acid: results of MRC AML 12

AK Burnett, Keith Wheatley, AH Goldstone, A Prentice

Cancer Research UK Clinical Trials Unit

Research output: Contribution to conference (unpublished) › Paper

Original language	English
Pages	159 Abs 529
Publication status	Published - 1 Jan 2002

Cite this

@conference{6c8fcc8a47c3449bacd1a359e3ffe5a6,

title = "Attempts to improve induction treatment in AML patients under 60 years: the impact of mitoxantrone; ARA-C dose and retinoid acid: results of MRC AML 12",

author = "AK Burnett and Keith Wheatley and AH Goldstone and A Prentice",

year = "2002",

month = jan,

day = "1",

language = "English",

pages = "159 Abs 529",

}